CCXI
Assenagon Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-542,817
| Closed | -$28M | – | 1453 |
|
2022
Q3 | $28M | Buy |
542,817
+403,598
| +290% | +$20.8M | 0.11% | 172 |
|
2022
Q2 | $3.45M | Sell |
139,219
-22,556
| -14% | -$559K | 0.01% | 632 |
|
2022
Q1 | $4.06M | Sell |
161,775
-69,687
| -30% | -$1.75M | 0.01% | 558 |
|
2021
Q4 | $8.43M | Buy |
+231,462
| New | +$8.43M | 0.02% | 339 |
|
2021
Q3 | – | Sell |
-104,213
| Closed | -$1.4M | – | 1425 |
|
2021
Q2 | $1.4M | Buy |
+104,213
| New | +$1.4M | ﹤0.01% | 779 |
|
2021
Q1 | – | Sell |
-49,294
| Closed | -$3.05M | – | 1305 |
|
2020
Q4 | $3.05M | Buy |
49,294
+39,186
| +388% | +$2.43M | 0.01% | 405 |
|
2020
Q3 | $554K | Buy |
+10,108
| New | +$554K | ﹤0.01% | 915 |
|
2019
Q4 | – | Sell |
-124,328
| Closed | -$843K | – | 950 |
|
2019
Q3 | $843K | Buy |
+124,328
| New | +$843K | 0.01% | 546 |
|